The next board meeting for Royalty Pharma PLC (Class A) is on 19 May 2026 for the purpose of RBC Capital Markets 2026 Global Healthcare ConferenceSee details
Royalty Pharma PLC (Class A) - RPRX - stock price prediction, stock price target, analyst ratings from 10 analysts
Royalty Pharma PLC (Class A) has a share price target of US$ 59, revenue growth forecast of 5.4%, and profit growth estimate of 107.1% for FY26, based on top 10 analyst calls.